The OA CRO
The contract research organization dedicated to clinical drug development and research within Osteoarthritis
Osteoarthritis Experts
In-depth expertise in OA and placebo response
- Customized protocol development and study execution based on your compound's mode of action
- Unique understanding of placebo response and risk mitigation in OA studies
- World-renowned science team publishing in high-ranking journals
Clinical Development
The OA CRO
- Decades of in-house scientific and full-service clinical trial experience
- Fast and efficient recruitment of eligible subjects with our unique feasibility approach FeasIntel™
- Pioneering cost efficiency through unique risk-sharing models
What is NBCD?
Nordic Bioscience Clinical Development (NBCD) is dedicated to clinical drug development, specializing in osteoarthritis and precision medicine using unique biomarker technologies.
Having worked 25+ years in biomarker development and clinical trials, NBCD has acquired extensive expertise in rheumatology. We are a one-stop shop for clinical trials in Osteoarthritis and are working close with our partners in Sanos Clinic, which are dedicated clinical research centers, and Sanos Patient Recruitment.
We have more than 50 articles published each year in well respected, peer-reviewed journals. This year we exceeded 500 publications in total with our colleagues in Nordic Bioscience A/S.
We tailor our unique solutions to our clients’ needs.
As a privately owned specialized company, we are able to make decisions swiftly, leverage cross-functional synergies and quickly adapt the organization to accommodate clients’ current and future needs.
